Atlas Research Digest: Smaller particles, in more of us, than thirty-three years ago

Almost everything indexed here answers a question about the present. Is there plastic in this water, this fish, this organ, this person? The harder question is whether the answer is changing, and it is hard because answering it needs samples nobody knew to save. One study in this group found some, in a hospital archive, and used them to put a number on how much has changed in us.

What reaches a pregnancy, and what that does not prove

The largest cluster of new human facing work concerns the placenta. One mouse study traced a full route from exposure to outcome: polystyrene nanoplastics depleted a mitochondrial enzyme called NMNAT3 in placental tissue, which drained the cell's NAD supply and tipped trophoblasts into an iron dependent form of cell death, with restricted fetal growth as the result. Restoring the enzyme, or supplying nicotinamide, prevented it. In human cells, polystyrene microplastics impaired the invasion step that trophoblasts must complete for a placenta to attach properly, and shifted the microRNAs that govern blood vessel growth. A review gathers this into a single organelle level model in which particles overload the lysosome, disorganize mitochondria and stress the endoplasmic reticulum. Set against all of it is a scoping review that does the field a service by drawing a line: evidence that microplastics reach the placenta, the amniotic fluid and the cord blood is not evidence that they cause congenital anomalies, and the human research that would settle that question has largely not been done.

Kidney patients, and the explanation that does not hold

A biomonitoring study measured micro and nanoplastic particles in the blood of people with chronic kidney disease and in healthy controls. Both patient groups carried far more than the controls: a median near 9,900 particles per milliliter in people on hemodialysis, about 9,200 in people with kidney disease who were not on dialysis, against roughly 5,800 in healthy subjects. The intuitive explanation is the dialysis circuit itself, all that tubing and all those filters. The data do not really support it, because the patients receiving no dialysis were nearly as high as those receiving it. Kidneys that clear less of what arrives fit the pattern better, and the study's other finding points the same way: urinary bisphenol A was lower in the kidney patients than in the healthy subjects, which is what reduced elimination looks like from the outside. A narrative review on the kidney sets out the same ambiguity at length, noting that the urinary system looks like both a target organ and a disposal route, and that no study yet defines a tissue dose or a threshold at which harm begins.

The particle rarely arrives alone

Plastic products shed both particles and the chemicals mixed into them, and two new animal studies were designed around that pairing rather than testing either half on its own. Young mice given food grade polypropylene microplastics together with the plasticizer DEHP showed less social interaction and exploration, more anxiety like behavior, and damage to neurons in the prefrontal cortex. A longer study paired polyethylene nanoplastics with a different phthalate and read the result out across individual brain cell types, finding the combination consistently worse than either exposure alone for spatial learning, hippocampal injury and the integrity of the barrier protecting the brain. The doses in both are well above what people encounter, and neither tells us what happens at ours. The methodological point survives that caveat. An experiment that isolates one variable is describing a situation that does not occur in isolation.

Counting is still the hard part

The lung comparison worked because both sets of samples went through one instrument in one laboratory. Comparisons across laboratories remain far shakier, and a review of blood measurement methods explains why: published studies differ in sample preparation, blood volume, the smallest particle each method can detect, and even the unit reported, which may be polymer mass, individually characterized particles, or fluorescent events. Those are not interchangeable, so the numbers cannot be lined up. The review also raises a statistical problem that rarely gets mentioned: when particles are scarce and the sample is a few milliliters, whether you find any at all is substantially a matter of chance. On the intake side, a dosimetry model of inhaled particles estimates that roughly 60 percent of what settles in the airways each day is cleared into the esophagus and swallowed, about 28 percent stays in the respiratory tract, and 0.4 percent crosses into blood. It also finds indoor air to be the larger source, which is where most people spend most of their lives.

Filters, and one question about the gut

Removal research produced its most concrete results in water. A cellulose filter paper given a positive surface charge retained 99.8 percent of particles between 0.1 and 100 micrometers while running far faster than ordinary filter paper, and a set of biopolymer meshes and balls modeled on seagrass trapped a broad span of particle sizes that filtration and centrifugation handle poorly. Both are laboratory results at laboratory scale. Separately, and much more tentatively, one group asked why some people appear to excrete more ingested plastic than others, linked the difference to gut bacteria across 138 individuals, and isolated a strain of Lactiplantibacillus plantarum from one of the high excretion donors. In mice fed a mixed plastic diet, colonization with that strain left less plastic in the intestinal tract. The same strain was then given to 106 people in a randomized, placebo controlled trial. The result reported first is not about particles at all. It is a decline of roughly 36 to 60 percent, depending on the compound, in several urinary phthalate metabolites, which are breakdown products of plasticizers rather than the plastic itself. That is a single strain, a single trial, and a set of chemical markers. It is a long way from a demonstrated health benefit, and the authors do not claim one.

What it adds up to

The Atlas indexes what gets published, the careful studies alongside the thin ones, and any single striking number is a reason to read the study rather than a conclusion to carry away. What stands out in this group is that the field is starting to acquire a time axis. For two decades the work has established presence: in oceans, in soil, in food, in blood, in placenta, in brain. Presence alone cannot tell you whether exposure is growing, and almost nothing is built to answer that, because answering it requires tissue somebody stored before there was a reason to ask. One hospital had it. What came back was more people affected, smaller particles, and a wider mix of polymers than a generation earlier. Whether that trajectory matters for health remains open. That there is a trajectory at all, rather than another snapshot, is the new thing.